Cargando…
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly worldwide since it was confirmed as the causative agent of COVID-19. Molecular diagnosis of the disease is typically performed via nucleic acid-based detection of the virus from swabs, sputum or bronchoalveolar lavage fl...
Autores principales: | Shen, Liang, Wang, Chunhua, Zhao, Jianzhong, Tang, Xiaoyong, Shen, Ying, Lu, Mingqing, Ding, Zhe, Huang, Canping, Zhang, Ji, Li, Shichao, Lan, Jiaming, Wong, Gary, Zhu, Yufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284968/ https://www.ncbi.nlm.nih.gov/pubmed/32476607 http://dx.doi.org/10.1080/22221751.2020.1766382 |
Ejemplares similares
-
Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China
por: Shen, Liang, et al.
Publicado: (2020) -
Protective Roles of Natural IgM Antibodies
por: Grönwall, Caroline, et al.
Publicado: (2012) -
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
Structure, Function, and Therapeutic Use of IgM Antibodies
por: Keyt, Bruce A., et al.
Publicado: (2020) -
Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
por: Luo, Chunhua, et al.
Publicado: (2021)